Page last updated: 2024-09-03

sr 48692 and miglustat

sr 48692 has been researched along with miglustat in 1 studies

Compound Research Comparison

Studies
(sr 48692)
Trials
(sr 48692)
Recent Studies (post-2010)
(sr 48692)
Studies
(miglustat)
Trials
(miglustat)
Recent Studies (post-2010) (miglustat)
20333638328185

Protein Interaction Comparison

ProteinTaxonomysr 48692 (IC50)miglustat (IC50)
Sucrase-isomaltase Mus musculus (house mouse)1.05
Maltase-glucoamylase, intestinalHomo sapiens (human)5.55
Lysosomal acid glucosylceramidaseHomo sapiens (human)5
Lysosomal alpha-glucosidaseHomo sapiens (human)0.1
Sucrase-isomaltase, intestinalHomo sapiens (human)0.5
Sucrase-isomaltase, intestinalRattus norvegicus (Norway rat)2.156
Protein-lysine 6-oxidaseHomo sapiens (human)5
Glycogen debranching enzymeHomo sapiens (human)10
Lysosomal alpha-glucosidaseMus musculus (house mouse)9
Non-lysosomal glucosylceramidaseMus musculus (house mouse)0.14
Lysosomal alpha-glucosidaseRattus norvegicus (Norway rat)3.7
Non-lysosomal glucosylceramidaseHomo sapiens (human)0.2057
Putative alpha-glucosidaseOryza sativa Japonica Group (Japanese rice)0.42

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Codd, R; Liao, V; Lifa, T; Liu, J; Obando, D1

Reviews

1 review(s) available for sr 48692 and miglustat

ArticleYear
The many faces of the adamantyl group in drug design.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Iron Chelating Agents; Iron Overload; Malaria; Solubility

2011